In fact, an early investigation including 4 clinical osteosarcoma samples by Sato et al. found there was no detectable E-cadherin expression in these cells [42], suggesting that the repression/downregulation of E-cadherin—a classically described step in EMT—would not be possible. The gene discussed is CDH1; the disease is osteosarcoma.